ACTRN12618001307291招募中未知
Diagnostic accuracy and clinical utility of PSMA PET/MRI Scanning in Prostate Cancer: The SAMURAI Trial
Australian Urology Associates0 个研究点目标入组 50 人开始时间: 2018年8月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Male
入选标准
- •(1) adult 18 years of age and above with new transperineal/transrectal biopsy diagnosed prostate cancer
- •(2) male sex
- •(3) eligible for definitive treatment with radical prostatectomy (based on age, medical co-morbidities, past history, disease progression/severity, life expectancy or other factors), as determined by the treating urologist
- •(4) eligible to undergo a Ga68 PSMA PET/CT scan as part of standard clinical care
- •(5) biopsy diagnosed cancer is intermediate risk prostate cancer or higher (greater than or equal to Gleason 3+4=7 or Grade Group 2)
- •(6) Signed, written, informed consent
排除标准
- •(1) <18 years old
- •(2) low risk prostate cancers (Less than or equal to Gleason 3+3=6 or Grade Group 1)
- •(3) previously diagnosed prostate cancers (includes treated and untreated prostate cancers)
- •(4) ineligible for definitive treatment with radical prostatectomy due to age, medical co-morbidities, past history, disease progression/severity, life expectancy or other factors as determined by the treating urologist
- •(5) contraindications to injection of Gallium 68 labelled PSMA radiotracer, magnetic resonance imaging and PET/CT
研究者
相似试验
进行中（未招募）
1 期
Evaluation of diagnostic accuracy of [68Ga]Ga-PSMA-11 PET/CT in primary staging of Intermediate and High Risk Prostatic Cancer in men newly diagnosedMen with histo-pathological confirmation of PCa with intermediate or high-risk disease according to 2019 Prostate Cancer EAU Guidelines Risk Group StratificationMedDRA version: 21.1Level: LLTClassification code 10036927Term: Prostate neoplasiaSystem Organ Class: 100000004864EUCTR2019-004685-18-ITAZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA100
已完成
不适用
Clinical research on [-2] proPSA measurement in a diagnosis of prostate cancer: prostate health index trial.Prostate cancerJPRN-UMIN000016934Clinical Research Support Center Kyushu300
招募中
不适用
Clinical research on [-2] proPSA measurement in a diagnosis of prostate cancer: prostate health index trial. Side study: head to head comparison between [-2] proPSA-related indices and MRIprostate cancerJPRN-UMIN000047187Department of Urology, Gunma University Graduate School of Medicine109
已完成
不适用
Role of PSMA-PET/MRI for diagnosis and follow-up of focal therapy of prostate cancerC61Malignant neoplasm of prostateDRKS00022363niversitätsmedizin Mannheim, Klinik für Urologie und Urochirurgie15
已完成
不适用
Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate CancerProstate CancerNCT02825875Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins200